Gilead Sciences at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Gilead Sciences brings 7 presentations to SCOPE 2027 in Orlando. Its sessions center on risk-based quality management and site monitoring performance, along with emerging oncology research sites. A concrete topic is using a matched real-world cohort as a safety benchmark for investigational and approved treatments.
| Organization | SCOPE 2027 Attendance |
|---|---|
Gilead Sciences Foster City, CA | |
Biopharmaceutical company with medicines for HIV, liver disease, cancer and inflammatory disease. | Panel Tue Mar 2 9:15am–9:45am Talk Tue Mar 2 11:30am–11:55am Talk Tue Mar 2 11:40am–11:55am Talk Wed Mar 3 8:35am–9:00am Oncology's Hidden Potential: A Sponsor & CRO Guide to Emerging Sites Site strategy and partnering Talk Thu Mar 4 8:35am–9:00am Panel Thu Mar 4 9:25am–9:50am Talk Thu Mar 4 11:42am–12:17pm |
Instantly find 20 buyers from Gilead Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction